269 related articles for article (PubMed ID: 37217614)
21. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
Front Immunol; 2018; 9():724. PubMed ID: 29719533
[TBL] [Abstract][Full Text] [Related]
22. The role of indoleamine 2,3-dioxygenase in allergic disorders.
Esmaeili SA; Hajavi J
Mol Biol Rep; 2022 Apr; 49(4):3297-3306. PubMed ID: 35028850
[TBL] [Abstract][Full Text] [Related]
23. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.
Zitron IM; Kamson DO; Kiousis S; Juhász C; Mittal S
Cancer Biol Ther; 2013 Apr; 14(4):333-9. PubMed ID: 23358471
[TBL] [Abstract][Full Text] [Related]
24. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.
Laurans L; Venteclef N; Haddad Y; Chajadine M; Alzaid F; Metghalchi S; Sovran B; Denis RGP; Dairou J; Cardellini M; Moreno-Navarrete JM; Straub M; Jegou S; McQuitty C; Viel T; Esposito B; Tavitian B; Callebert J; Luquet SH; Federici M; Fernandez-Real JM; Burcelin R; Launay JM; Tedgui A; Mallat Z; Sokol H; Taleb S
Nat Med; 2018 Aug; 24(8):1113-1120. PubMed ID: 29942089
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.
Yamasuge W; Yamamoto Y; Fujigaki H; Hoshi M; Nakamoto K; Kunisawa K; Mouri A; Nabeshima T; Saito K
Cancer Sci; 2019 Oct; 110(10):3061-3067. PubMed ID: 31444833
[TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3-dioxygenase: is it an immune suppressor?
Soliman H; Mediavilla-Varela M; Antonia S
Cancer J; 2010; 16(4):354-9. PubMed ID: 20693847
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.
Fatokun AA; Hunt NH; Ball HJ
Amino Acids; 2013 Dec; 45(6):1319-29. PubMed ID: 24105077
[TBL] [Abstract][Full Text] [Related]
28. [Indoleamine 2,3-dioxygenase in oncology and psychiatry].
Vonka V; Horáček J
Cas Lek Cesk; 2015; 154(1):3-10. PubMed ID: 25994821
[TBL] [Abstract][Full Text] [Related]
29. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.
Thomas SR; Stocker R
Redox Rep; 1999; 4(5):199-220. PubMed ID: 10731095
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan-indoleamine 2,3-dioxygenase 1-kynurenine pathway during intra-abdominal sepsis.
Xie T; Lv T; Zhang T; Feng D; Zhu F; Xu Y; Zhang L; Gu L; Guo Z; Ding C; Gong J
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):1046-1059. PubMed ID: 36880228
[TBL] [Abstract][Full Text] [Related]
31. Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice.
Magliocca A; Perego C; Motta F; Merigo G; Micotti E; Olivari D; Fumagalli F; Lucchetti J; Gobbi M; Mandelli A; Furlan R; Skrifvars MB; Latini R; Bellani G; Ichinose F; Ristagno G
Anesthesiology; 2023 Nov; 139(5):628-645. PubMed ID: 37487175
[TBL] [Abstract][Full Text] [Related]
32. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.
Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A
FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623
[TBL] [Abstract][Full Text] [Related]
33. ATP promotes immunosuppressive capacities of mesenchymal stromal cells by enhancing the expression of indoleamine dioxygenase.
Lotfi R; Steppe L; Hang R; Rojewski M; Massold M; Jahrsdörfer B; Schrezenmeier H
Immun Inflamm Dis; 2018 Dec; 6(4):448-455. PubMed ID: 30306723
[TBL] [Abstract][Full Text] [Related]
34. Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.
Amobi A; Qian F; Lugade AA; Odunsi K
Adv Exp Med Biol; 2017; 1036():129-144. PubMed ID: 29275469
[TBL] [Abstract][Full Text] [Related]
35. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
36. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
37. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels.
Grant R; Kapoor V
Biochem Pharmacol; 2003 Sep; 66(6):1033-6. PubMed ID: 12963490
[TBL] [Abstract][Full Text] [Related]
39. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response.
Suh HS; Zhao ML; Rivieccio M; Choi S; Connolly E; Zhao Y; Takikawa O; Brosnan CF; Lee SC
J Virol; 2007 Sep; 81(18):9838-50. PubMed ID: 17626075
[TBL] [Abstract][Full Text] [Related]
40. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
